182 related articles for article (PubMed ID: 22243962)
1. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
Lee J; Bogyo M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
[TBL] [Abstract][Full Text] [Related]
2. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.
Sexton KB; Witte MD; Blum G; Bogyo M
Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693
[TBL] [Abstract][Full Text] [Related]
3. Mammalian legumain - A lysosomal cysteine protease with extracellular functions?
Lunde NN; Bosnjak T; Solberg R; Johansen HT
Biochimie; 2019 Nov; 166():77-83. PubMed ID: 31181234
[TBL] [Abstract][Full Text] [Related]
4. Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain.
Lee J; Bogyo M
ACS Chem Biol; 2010 Feb; 5(2):233-43. PubMed ID: 20017516
[TBL] [Abstract][Full Text] [Related]
5. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the development of legumain-selective chemical probes and peptide prodrugs.
Poreba M
Biol Chem; 2019 Nov; 400(12):1529-1550. PubMed ID: 31021817
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and
Corrigan TS; Lotti Diaz LM; Border SE; Ratigan SC; Kasper KQ; Sojka D; Fajtova P; Caffrey CR; Salvesen GS; McElroy CA; Hadad CM; Doğan Ekici Ö
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1387-1402. PubMed ID: 32633155
[TBL] [Abstract][Full Text] [Related]
8. Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes.
Poreba M; Solberg R; Rut W; Lunde NN; Kasperkiewicz P; Snipas SJ; Mihelic M; Turk D; Turk B; Salvesen GS; Drag M
Cell Chem Biol; 2016 Aug; 23(8):1023-35. PubMed ID: 27478158
[TBL] [Abstract][Full Text] [Related]
9. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
[TBL] [Abstract][Full Text] [Related]
10. Specificity of aza-peptide electrophile activity-based probes of caspases.
Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
[TBL] [Abstract][Full Text] [Related]
11. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo.
Li DN; Matthews SP; Antoniou AN; Mazzeo D; Watts C
J Biol Chem; 2003 Oct; 278(40):38980-90. PubMed ID: 12860980
[TBL] [Abstract][Full Text] [Related]
12. N-Terminomics/TAILS Profiling of Macrophages after Chemical Inhibition of Legumain.
Anderson BM; de Almeida LGN; Sekhon H; Young D; Dufour A; Edgington-Mitchell LE
Biochemistry; 2020 Jan; 59(3):329-340. PubMed ID: 31774660
[TBL] [Abstract][Full Text] [Related]
13. The Mammalian Cysteine Protease Legumain in Health and Disease.
Solberg R; Lunde NN; Forbord KM; Okla M; Kassem M; Jafari A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555634
[TBL] [Abstract][Full Text] [Related]
14. Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
Ovat A; Muindi F; Fagan C; Brouner M; Hansell E; Dvorák J; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
J Med Chem; 2009 Nov; 52(22):7192-210. PubMed ID: 19848405
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and properties of the first all-aza analogue of a biologically active peptide.
Gante J; Krug M; Lauterbach G; Weitzel R; Hiller W
J Pept Sci; 1995; 1(3):201-6. PubMed ID: 9222997
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of legumain in health and disease.
Dall E; Brandstetter H
Biochimie; 2016 Mar; 122():126-50. PubMed ID: 26403494
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel homoazanucleosides and their peptidyl analogs.
Salunke RV; Mishra PK; Sanghvi YS; Ramesh NG
Org Biomol Chem; 2020 Jul; 18(29):5639-5651. PubMed ID: 32724966
[TBL] [Abstract][Full Text] [Related]
18. Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice.
Shirahama-Noda K; Yamamoto A; Sugihara K; Hashimoto N; Asano M; Nishimura M; Hara-Nishimura I
J Biol Chem; 2003 Aug; 278(35):33194-9. PubMed ID: 12775715
[TBL] [Abstract][Full Text] [Related]
19. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
